Concepedia
Statistics
Publications
21
Citations
730
H-Index
16
Active since
2015
Affiliations
Chinese University of Hong Kong(Current)
Prince of Wales Hospital
National Cancer Centre Singapore
Hong Kong Polytechnic University
Leung Li is an author at Chinese University of Hong Kong specializing in oncology, medicine, and chemotherapy.
Publications per year
2015–2024
Phase I/II study of temsirolimus for patients with unresectable Hepatocellular Carcinoma (HCC)- a correlative study to explore potential biomarkers for response
Winnie Yeo, Stephen L. Chan, Frankie Mo et al. · BMC Cancer · 2015 · 134 citations · Full text
Medicine, Oncology, Pharmacology +17
Efficacy, Safety, and Pharmacokinetics of Axitinib in Nasopharyngeal Carcinoma: A Preclinical and Phase II Correlative Study
Edwin P. Hui, Herbert H. Loong, Frankie Mo et al. · Clinical Cancer Research · 2018 · 73 citations · Full text
Medicine, Oncology, Pharmacology +13
Prognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma – clinical application of health-related quality-of-life data
Leung Li, Frankie Mo, Stephen L. Chan et al. · BMC Cancer · 2017 · 53 citations · Full text
Medicine, Oncology, Cancer Control +15
Multicentre phase II trial of cabozantinib in patients with hepatocellular carcinoma after immune checkpoint inhibitor treatment
Stephen L. Chan, Baek‐Yeol Ryoo, Frankie Mo et al. · Journal of Hepatology · 2024 · 53 citations
Medicine, Oncology, Pharmacology +14
A phase II clinical study on the efficacy and predictive biomarker of pegylated recombinant arginase on hepatocellular carcinoma
Stephen L. Chan, Paul N. Cheng, Angela M. Liu et al. · Investigational New Drugs · 2021 · 45 citations · Full text
Medicine, Oncology, Pharmacology +15
1–5 of 21